Purchase Order 75N94025P00392
Award Date 7/18/25
Potential Completion Date 7/17/26
Potential Value $90K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $17,380 purchase order to Oxford Nanopore Technologies Inc. for CAS9 sequencing kits. The firm fixed price order is for delivery of the requested products between July 24 and August 4, 2023. Oxford Nanopore Technologies Inc. will perform as the prime contractor, with all work taking place in New York, NY....
- The Department of Health and Human Services National Institutes of Health National Institute on Alcohol Abuse and Alcoholism awarded a firm fixed price purchase order valued at thirty-two thousand two hundred eighty dollars to Oxford Nanopore Technologies Inc. for DNA sequencing kits and PromethION flow cell packs. The solicitation requested quotes for six ultra-long DNA sequencing kits and one pack of eight PromethION flow cells to support long read DNA and RNA sequencing on the awardee's...
- This is a firm fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The $55,075 contract is for the delivery of RNA sequencing kits and related packs. This award does not utilize a set-aside designation. Oxford Nanopore Technologies is a major provider of advanced genomic sequencing equipment, consumables, and services to various federal...
- The National Institute on Drug Abuse awarded a $2.96 million firm fixed-price purchase order to Oxford Nanopore Technologies Inc. on September 14, 2020, for the delivery of long-read sequencing kits to support the Laboratory of Neurogenetics' neurodegenerative disease research initiatives. The contract, which was completed on November 13, 2020, involved no set-aside designation and specified performance at Oxford Nanopore's Cambridge, Massachusetts location. Oxford Nanopore Technologies Inc.,...
- This is a $23,050.00 firm fixed price purchase order awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of a PromethION 2 Solo CAPEX Sequencing Unit, a next-generation genomic sequencing platform developed by Oxford Nanopore. This award is not associated with a set-aside program and is the latest in a...
- Oxford Nanopore Technologies Inc. was awarded a firm fixed-price purchase order valued at $354,850 by the National Institute on Drug Abuse on September 16, 2020, for the provision of full-length RNA sequencing supplies to support the National Institute on Aging's research activities. The contract, which was completed on June 15, 2022, was not associated with any set-aside designation. The supplies were to be delivered to Cambridge, Massachusetts, and the award was issued in part to...
- The National Institute on Aging awarded a $24,995 firm fixed-price purchase order to Oxford Nanopore Technologies Inc. for software licenses and device warranty services related to the PromethION-24 sequencer. The contract was awarded on August 15, 2025, with an ultimate completion date of August 14, 2026, and will be performed in New York, NY. This award carries no set-aside designation and represents Oxford Nanopore's continued provision of next-generation sequencing technologies to federal...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $101,655.00 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for a Nanopore Technology Sequencing Instrument. The contract has no set-aside designation and was awarded on September 26, 2019, with a completion date of October 31, 2019. Oxford Nanopore Technologies Inc. is a division of Oxford Nanopore Technologies PLC,...
- This federal contract award, valued at $44,838.00, was made by the National Institute on Aging (NIA), a civilian agency under the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the procurement of Promethion flow cell packs and ligation sequencing kits, which are used in Oxford Nanopore's next-generation genomic sequencing platforms. The contract is a firm fixed-price purchase order with a...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Oxford Nanopore Technologies Inc. for the purpose of purchasing long read sequencing on Oxford Nanopore manufactured sequencing systems. The contract has a potential value of $130,236.00 and a completion date of June 29, 2021. The parent company of the awardee is Oxford Nanopore Technologies PLC. There was no set-aside designation...